CountryFocus: Healthcare, Regulatory and Reimbursement Landscape ? France is a new market research publication announced by Reportstack. This report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.
The population of France in 2016 was 64.6 million, which increased gradually from 62.5 million in 2009. The French National Authority for Health (Haute Autorité de Santé or HAS) and the Commission for Economic Evaluation and Public Health (Commission d’Évaluation Économique et de Santé Publique; CEESP) started an economic evaluation in October 2013, for the assessment or reassessment of drugs and medical devices under certain circumstances.
Complete report available @ CountryFocus: Healthcare, Regulatory and Reimbursement Landscape ? France
In 2016, the government spent 11.6% of GDP on healthcare expenditure and exported $29.4 billion of pharmaceutical products. The pharmaceutical market in France was worth $35.59 billion in 2016, with a growth in generic drugs market. The volume of generic drug market increased from 23.6% in 2009 to 36.3% in 2016. The medical device market was valued at $18.2 billion in 2016 and is projected to grow at a CAGR of 4% to $22.5 billion by 2021. These positive growth trends can be primarily attributed to:
An increasingly elderly population
Universal health coverage
Government initiatives
Scope
Universal health coverage
Government initiatives
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, Sanofi, Pfizer, Merck & Co. and Mylan; and profiles and SWOT analyses of the major players in the medical device market: B. Braun Melsungen, Medtronic, Roche, Johnson & Johnson and GlaxoSmithKline (GSK)
An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the French healthcare market
Reasons to buy
Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, Sanofi, Pfizer, Merck & Co. and Mylan; and profiles and SWOT analyses of the major players in the medical device market: B. Braun Melsungen, Medtronic, Roche, Johnson & Johnson and GlaxoSmithKline (GSK)
An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the French healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving French healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact France’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact France’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment